Department of Cardiovascular Medicine, Texas Tech University Health Science Center El Paso, 4800 Alberta Avenue, El Paso, TX, USA.
Curr Cardiol Rep. 2022 Jul;24(7):801-805. doi: 10.1007/s11886-022-01699-0. Epub 2022 May 7.
This review provides a contemporary perspective and approach for the treatment of hypertension (HTN) among patients hospitalized for non-cardiac reasons.
Elevated blood pressure (BP) is a common dilemma encountered by physicians, but guidelines are lacking to assist providers in managing hospitalized patients with elevated BP. Inpatient HTN is common, and management remains challenging given the paucity of data and misperceptions among training and practicing physicians. The outcomes associated with intensifying BP treatment during hospitalization can be harmful, with little to no long-term benefits. Data also suggests that medication intensification at discharge is not associated with improved outpatient BP control. Routine inpatient HTN control in the absence of end-organ damage has not shown to be helpful and may have deleterious effects. Since routine use of intravenous antihypertensives in hospitalized non-cardiac patients has been shown to prolong inpatient stay without benefits, their routine use should be avoided for inpatient HTN control. Future large-scale trials measuring clinical outcomes during prolonged follow-up may help to identify specific circumstances where inpatient HTN control may be beneficial.
本文就非心脏原因住院患者的高血压(HTN)治疗提供了当代观点和方法。
血压升高是临床医生经常面临的难题,但目前缺乏指南来帮助临床医生管理住院伴有血压升高的患者。住院期间高血压很常见,由于数据缺乏以及培训和执业医师的误解,管理仍然具有挑战性。强化住院期间血压治疗的结果可能有害,几乎没有长期获益。数据还表明,出院时药物强化与改善门诊血压控制无关。在没有靶器官损害的情况下常规进行住院期间 HTN 控制无助于改善预后,甚至可能有害。由于静脉内降压药在住院非心脏患者中的常规使用已被证明会延长住院时间而没有获益,因此应避免其常规用于住院 HTN 控制。未来的大规模试验,通过长期随访来测量临床结局,可能有助于确定住院 HTN 控制可能有益的具体情况。